Top Pulmonary News of 2016: Can You Pass the Quiz?

December 28, 2016

This year on Medscape, some of the most popular news for pulmonologists was new drug approvals, the effect of vitamin D on asthma, and even some insight on how MACRA may take a bite out of their earnings. How much do you remember? Take our quiz to find out.

FDA Approves Reslizumab

In March, the US Food and Drug Administration (FDA) approved the monoclonal antibody reslizumab (Cinqair, Teva Pharmaceuticals) as a maintenance drug for adults with severe asthma.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: